Nirtetralin inhibits growth of hepatitis E virus in HepaRG cells

Authors

  • Wu-Jing Zhang Department of Infection, Laiwu People?s Hospital, Laiwu 271100
  • Ying-Bin Zhu Department of Infection, Laiwu People?s Hospital, Laiwu 271100
  • Guo-Dong Zhang Department of Infection, Laiwu People?s Hospital, Laiwu 271100

DOI:

https://doi.org/10.3329/bjp.v10i2.20923

Keywords:

Nirtetralin, HepaRG™ cell lines, Hepatitis E virus

Abstract

Among numerous established in human hepatoma cell lines, none has been shown susceptible to hepatitis E virus (HEV) infection. Differentiation and infect ability are maintained but when these cells are cultured in the presence of corticoids and dimethyl sulfoxide. On exposure to the nirtetralin, the virion particles were found to be decreased with an IC50 of 2.277. Quantitative analysis of total and closed circular HEV RNA by real-time PCR performed on five independent experiments showed that only 1-5% of the HEV RNA internalized at day 1 post-infection entered the core of the cell refinement. The knockdown of 4E-BP1 led to a 1.7 ± 0.6-fold (mean ± SD, n = 5, p<0.01) and 2.4 ± 0.9-fold (mean ± SD, n = 4, p<0.05) (by the clone 56) growth of HEV RNA, respectively. Duncan's multiple range tests were applied to compare the differences between the treatment groups.

 

Downloads

Download data is not yet available.
Abstract
274
Download
187 Read
268

Downloads

Additional Files

Published

2015-04-23

How to Cite

Zhang, W.-J., Y.-B. Zhu, and G.-D. Zhang. “Nirtetralin inhibits Growth of Hepatitis E Virus in HepaRG Cells”. Bangladesh Journal of Pharmacology, vol. 10, no. 2, Apr. 2015, pp. 377-82, doi:10.3329/bjp.v10i2.20923.

Issue

Vol. 10 No. 2 (2015)

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).